Liquidia (LQDA) Total Current Liabilities (2019 - 2026)
Liquidia (LQDA) posted quarterly Total Current Liabilities of $149.7 million for Q1 2026, up 147.43% year-over-year from $60.5 million in Q1 2025, and up 10.29% quarter-over-quarter from $135.8 million in Q4 2025.
Liquidia (LQDA) Total Current Liabilities (2019 - 2026) Analysis & Trends
Liquidia's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $149.7 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 147.43% year-over-year to $149.7 million; the TTM figure through Mar 2026 stood at $149.7 million (up 147.43% YoY), while the FY2025 annual figure was $135.8 million, up 224.95% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $149.7 million, up from $135.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $149.7 million in Q1 2026, with the low at $6.8 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $21.9 million (2024), against an average of $43.4 million.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities fell 14.49% in 2023, then soared 224.95% in 2025.
- Liquidia's Total Current Liabilities stood at $8.8 million in 2022, then jumped by 110.8% to $18.6 million in 2023, then jumped by 125.23% to $41.8 million in 2024, then jumped by 224.95% to $135.8 million in 2025, then advanced by 10.29% to $149.7 million in 2026.
- Business Quant data shows LQDA's Total Current Liabilities at $149.7 million in Q1 2026, $135.8 million in Q4 2025, and $102.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Liquidia | 6.39 Bn | 6.11 Bn | 160.92 Mn | 189.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 189.30 Mn |
| Mar 31, 2026 | 149.74 Mn |
| Dec 31, 2025 | 135.77 Mn |
| Sep 30, 2025 | 102.94 Mn |
| Jun 30, 2025 | 78.41 Mn |
| Mar 31, 2025 | 60.52 Mn |
| Dec 31, 2024 | 41.78 Mn |
| Sep 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 24.22 Mn |
| Mar 31, 2024 | 21.93 Mn |
| Dec 31, 2023 | 18.55 Mn |
| Sep 30, 2023 | 12.16 Mn |
| Jun 30, 2023 | 19.50 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 7.46 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Mar 31, 2022 | 7.98 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 7.06 Mn |